|
1) Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J. 1993; 6: 1368-70
|
|
|
|
2) Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994; 343: 133-5
|
|
|
|
|
3) Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004; 169: 473-8
|
|
|
|
|
|
4) Baraldi E, de Jongste JC on behalf of the Task Force. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J. 2002; 20: 223-37
|
|
|
|
|
|
5) Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005; 352: 2163-73
|
|
|
|
|
|
6) Pijnenburg MW, Bakker EM, Hop WC, et al. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005; 172: 831-6
|
|
|
|
|
|
7) Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998; 53: 91-5
|
|
|
|
|
|
8) Payne DN, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001; 164: 1376-81
|
|
|
|
|
|
9) Lehtimäki L, Turjanmaa V, Kankaanranta H, et al. Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates. Ann Med. 2000; 32: 417-23
|
|
|
|
|
|
10) ATS/ERS recommendation for standardized procedures for the online and offline measure-ment of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171: 912-30
|
|
|
|
|
|
11) Mandhane PJ, Hanna SE, Inman MD, et al. Changes in exhaled nitric oxide related to estrogen and progesterone during the menstrual cycle. Chest. 2009; 136: 1301-7
|
|
|
|
|
|
12) Saito J, Sato S, Hasunuma H, et al. Off-line fractional exhaled nitric oxide measurement is useful to screen allergic airway inflammation in an adult population. J Asthma. 2007; 44: 805-10
|
|
|
|
|
|
13) Alving K, Janson C, Nordvall L. Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res. 2006; 7: 67
|
|
|
|
|
|
14) Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004; 169: 473-8
|
|
|
|
|
|
15) Pavord ID, Brightling CE, Woltmann G, et al. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999; 353: 2213-4
|
|
|
|
|
|
16) Taylor DR, Pijnenburg MW, Smith AD, et al. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006; 61: 817-27
|
|
|
|
|
|
17) Ichinose M, Sugiura H, Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease air-ways. Am J Resper Crit Care Med. 2000; 162: 701-6
|
|
|
|
|
|
18) Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000; 356: 1480-5
|
|
|
|
|
|
19) Kharitonov SA, Barns PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001; 163: 1693-722
|
|
|
|
|
|
20) Brugière O, Thabut G, Mal H, et al. Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome. Eur Respir J. 2005; 25: 813-9
|
|
|
|
|
|
21) Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol. 2005; 116: 1249-55
|
|
|
|
|
|
22) Delgado-Corcoran C, Kissoon N, Murphy SP, et al. Exhaled nitric oxide reflects asthma severity and asthma control. Pediatr Crit Care Med. 2004; 5: 48-52
|
|
|
|
|
|
23) Vahlkvist S, Sinding M, Skamstrup K, et al. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J Allergy Clin Immunol. 2006; 117: 1272-6
|
|
|
|
|
|
24) Aronsson D, Tufvesson E, Bjermer L. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy. 2005; 35: 1457-61
|
|
|
|
|
|
25) Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma manage-ment: a randomized controlled trial. Am J Respir Crit Care Med. 2007; 176: 231-7
|
|
|
|
|
|
26) Senna G, Passalacqua G, Schiappoli M, et al. Correlation among FEV, nitric oxide and asthma control test in newly diagnosed asthma. Allergy. 2007; 62: 207-8
|
|
|
|
|
|
27) US Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program, Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma. 2007
|
|
|
|
|
|
28) Harkins MS, Fiato KL, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma. 2004; 41: 471-6
|
|
|
|
|
|
29) Gelb AF, Flynn Taylor C, Shinar CM, et al. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest. 2006; 129: 1492-9
|
|
|
|
|
|
30) Saito J, Inokoshi Y, Saito K, et al. Usefullness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control. Eur Respir J. 2008; 32(Suppl): 52, 771s
|
|
|
|
|
|
31) Gruchalla RS, Sampson HA, Matsui E, et al. Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence. J Allergy Clin Immunol. 2009; 124: 213-21
|
|
|
|
|
|
32) Sato R, Tomita K, Tohda Y, et al. The strategy for predicting a future exacerbation of asthma using a combination of the Asthma Control TestTM and lung function tests. J Asthma. 2009; 46: 677-82
|
|
|
|
|
|
33) Williamson PA, Vaidyanathan S, Lipworth BJ. Emerging techniques to assess small airway disease: alveolar nitric oxide and impulse oscillometry. Thorax. 2008; 63: A19
|
|
|
|
|
|
34) Horvàth I, Loukides S, Wodehouse T, et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax. 2003; 58: 68-72
|
|
|
|
|